JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 44(2010) N 1 p. 23-27;
S.V. Buikin1*, M.V. Golubenko1, V.P. Puzyrev1,2

Genes for Mitochondria in Arterial Hypertension and Left Ventricular Hypertrophy

1Institute of Medical Genetics, Tomsk Research Center, Siberian Division, Russian Academy of Medical Sciences, Tomsk, 634050, Russia
2Russian Ministry of Health and Social Development, Siberian State Medical University, Tomsk, 634050, Russia

*stepan.buikin@medgenetics.ru
Received - 2009-06-24; Accepted - 2009-07-09

Study is devoted to "genes for mitochondria" - genes of mitochondrial genome and mitochondrial DNA polymerase γ gene (POLG1). We com pared frequencies of polymorphisms in mitochondrial DNA and in POLG1 between healthy individuals and patients with arterial hypertension, as well as between patients with and without left ventricular hypertrophy. We did not discover significant differences of distribution of C allele of MspIpolymorphism in POLG1 in studied group. We have shown higher prevalence of mitochondrial haplogroup H of mtDNA in patients without left ventricle hypertrophy (OR = 0.42; 95%CI 0.17-0.98; р = 0.043), while compared with patients having this complication. Haplogroup T was more fre quently detected in patients with left ventricle hypertrophy (OR = 6.16; 95%CI 1.17-9.74; р = 0.018). This result sug gest implication of mitochondrial DNA in hypertensioninduced left venticular hypertrophy.

arterial hypertension, left ventricular hypertrophy, analysis of association, common disease, mtDNA, POLG1



JMB-FOOTER RAS-JOURNALS